Maxime Verhoeven

248 Addendum LIST OF CONFERENCE ABSTRACTS Development of a disease activity index for rheumatoid arthritis patients using HandScan. Poster presentation at the ACR congress 2020, November 6-11, e-Congress. Development of a disease activity index for rheumatoid arthritis patients using HandScan. Poster presentation at the EULAR congress 2020, June 3-6, e-Congress. Impact on costs and quality of life over 5 years of treat-to-target treatment strategies initiating tocilizumab, methotrexate or their combination in early rheumatoid arthritis. Economic evaluation of the U-Act-Early trial. Poster presentation at the ACR congress 2019, November 8-13, Atlanta, GA, USA. Validation of a prognostic multivariable prediction model for insufficient clinical response to methotrexate in early rheumatoid arthritis. Poster presentation at the ACR congress 2019, November 8-13, Atlanta, GA, USA. Individual patient data meta-analysis of the effectiveness of tocilizumab on inhibiting radiographic progression in rheumatoid arthritis. Poster presentation at the NVR congress 2019, September 25-27, Arnhem, the Netherlands. Individual patient data meta-analysis of the effectiveness of tocilizumab on inhibiting radiographic progression in rheumatoid arthritis. Poster presentation at the EULAR congress 2019, June 12-15, Madrid, Spain. Does initiating tocilizumab lead to better disease control compared to initiating MTX with low-moderate dose prednisone in early rheumatoid arthritis; an indirect comparison of U-Act-Early and CAMERA-II treat-to-target trials. Poster presentation at the EULAR congress 2019, June 12-15, Madrid, Spain. Effectiveness of remission-induction strategies for early rheumatoid arthritis: a systematic literature review. Poster presentation at the EULAR congress 2019, June 12-15, Madrid, Spain. U-Act-Early trial 3 years follow-up: Radiographic joint damage and use of bDMARDs over 5 years in early RA patients treated-to-target with strategies initiating tocilizumab, methotrexate or their combination. Poster presentation at the ACR congress 2018, October 19-24, Chicago, IL, USA.